NCT07904650
PRP Versus Saline Hydrodissection for CTS RCT
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 1 with changes below, 1 re-verified with no change.
- Study First Submitted
Endpoints
Primary
Secondary (4)
Arms and interventions
Participants underwent a 15-mL venipuncture, and approximately 5 mL of autologous platelet-rich plasma (PRP) was prepared with the Arthrex ACP double-syringe system (centrifugation at 1500 rpm for 5 minutes). A single ultrasound-guided hydrodissection of the median nerve was performed at the carpal tunnel inlet with 5 mL of PRP per treated wrist, injected circumferentially around the nerve through a 22-gauge needle using an in-plane ulnar approach. No local anesthetic was used. In participants with bilateral carpal tunnel syndrome, both wrists were treated in the same session, each with a separate 5-mL injectate.
Participants underwent an identical 15-mL venipuncture to maintain blinding; the blood was discarded. A single ultrasound-guided hydrodissection of the median nerve was performed at the carpal tunnel inlet with 5 mL of 0.9% sodium chloride per treated wrist, delivered from a masked syringe and injected circumferentially around the nerve through a 22-gauge needle using an in-plane ulnar approach. No local anesthetic was used. In participants with bilateral carpal tunnel syndrome, both wrists were treated in the same session, each with a separate 5-mL injectate.
Biologicals: Autologous platelet-rich plasma
Other: Normal Saline (0.9% Sodium Chloride)
Procedures: Ultrasound-guided median nerve hydrodissection
Sites
1 site in 1 country
- Medical University of LodzLodz, Łódź Voivodeship, Poland